Drugs / follicle-stimulating hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02310919 | Sep 2014 → Jun 2018 | infertility disorder | University of California, San Francisco | Completed | Met primary |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2025-05-03 | Ferring Pharmaceuticals | Results Ferring Pharmaceuticals announces results of the IRIS Study: A comparative analysis of individualised vs.conventional recombinant follicular stimulating hormone dosing in Indian infertile patients ferring.com ↗
The study shows comparable efficacy and safety of individualized dosing of follitropin delta versus conventional dosing of follitropin alfa on ovarian stimulation, with reported rates of ongoing pregnancy rate and live birth rate in follitropin delta numerically higher. |
| 2024-05-17 | Ferring Pharmaceuticals | Results Ferring announces results demonstrating the efficacy and safety of follitropin delta for women undergoing in vitro fertilisation using an agonist protocol ferring.com ↗
Results from this randomised, controlled, open-label, multicentre trial showed that a statistically significant mean difference of 1.3 extra oocytes (95% CI: 0.22; 2.40, p=0.0185) were retrieved for women using the GnRH agonist protocol versus women using antagonist protocol. |
All press releases naming this drug 2 releases
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | follicle-stimulating hormone | “OBJECTIVE: To assess if triggering with 1,500 IU of human chorionic gonadotropin (hCG) with 450 IU of follicle-stimulating hormone (FSH) induces noninferior oocyte competence...” PMID 35705380 ↗ Jun 2022 |
| Known as | FSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02310919 ↗ |
| Route | Subcutaneous | “hCG 1,500 IU SQ + FSH 450 IU SQ.” NCT02310919 ↗ |